Cargando…

Molecular characterization of invasive Neisseria meningitidis isolates collected in Lithuania (2009-2019) and estimation of serogroup B meningococcal vaccine 4CMenB and MenB-Fhbp coverage

Neisseria meningitidis causes invasive meningococcal disease (IMD), which is associated with significant mortality and long-term consequences, especially among young children. The incidence of IMD in Lithuania was among the highest in European Union/European Economic Area countries during the past t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sereikaitė, Emilija, Plepytė, Rūta, Petrutienė, Aurelija, Stravinskienė, Dovilė, Kučinskaitė-Kodzė, Indrė, Gėgžna, Vilmantas, Ivaškevičienė, Inga, Žvirblienė, Aurelija, Plečkaitytė, Milda
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Cellular and Infection Microbiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9975601/ https://www.ncbi.nlm.nih.gov/pubmed/36875527 http://dx.doi.org/10.3389/fcimb.2023.1136211

Ejemplares similares

Construction of polyomavirus-derived pseudotype virus-like particles displaying a functionally active neutralizing antibody against hepatitis B virus surface antigen
por: Pleckaityte, Milda, et al.
Publicado: (2015)

Mapping of Recognition Sites of Monoclonal Antibodies Responsible for the Inhibition of Pneumolysin Functional Activity
por: Kucinskaite-Kodze, Indre, et al.
Publicado: (2020)

Immunogenic Properties and Antigenic Similarity of Virus-like Particles Derived from Human Polyomaviruses
por: Lučiūnaitė, Asta, et al.
Publicado: (2023)

Molecular characteristics of Neisseria meningitidis carriage strains in university students in Lithuania
por: Ivaškevičienė, Inga, et al.
Publicado: (2023)

‘Be on the TEAM’ Study (Teenagers Against Meningitis): protocol for a controlled clinical trial evaluating the impact of 4CMenB or MenB-fHbp vaccination on the pharyngeal carriage of meningococci in adolescents
por: Carr, Jeremy, et al.
Publicado: (2020)

Persistence of SARS-CoV-2-Specific Antibodies for 13 Months after Infection
por: Kučinskaitė-Kodzė, Indrė, et al.
Publicado: (2021)

Production in yeast of pseudotype virus-like particles harboring functionally active antibody fragments neutralizing the cytolytic activity of vaginolysin
por: Pleckaityte, Milda, et al.
Publicado: (2011)

Meningococcal B Vaccination (4CMenB) in Infants and Toddlers
por: Esposito, Susanna, et al.
Publicado: (2015)

Activation of NLRP3 Inflammasome by Virus-Like Particles of Human Polyomaviruses in Macrophages
por: Lučiūnaitė, Asta, et al.
Publicado: (2022)

4CMenB vaccine induces elite cross-protective human antibodies that compete with human factor H for binding to meningococcal fHbp
por: Veggi, Daniele, et al.
Publicado: (2020)

Insights into the CRISPR/Cas system of Gardnerella vaginalis
por: Pleckaityte, Milda, et al.
Publicado: (2012)

A physician’s guide to the 2-dose schedule of MenB-FHbp vaccine
por: McDaniel, Angee, et al.
Publicado: (2019)

Looking beyond meningococcal B with the 4CMenB vaccine: the Neisseria effect
por: Ruiz García, Yara, et al.
Publicado: (2021)

The Cytolytic Activity of Vaginolysin Strictly Depends on Cholesterol and Is Potentiated by Human CD59
por: Zilnyte, Milda, et al.
Publicado: (2015)

Evaluation of Trichodysplasia Spinulosa-Associated Polyomavirus Capsid Protein as a New Carrier for Construction of Chimeric Virus-Like Particles Harboring Foreign Epitopes
por: Gedvilaite, Alma, et al.
Publicado: (2015)

Fever-Associated Supraventricular Tachycardia after 4CMenB Vaccination in an Infant
por: Gönüllü, Erdem, et al.
Publicado: (2019)

Multicomponent meningococcal B vaccination (4CMenB) of adolescents and college students in the United States
por: Banzhoff, Angelika
Publicado: (2017)

The Use of Chimeric Virus-like Particles Harbouring a Segment of Hantavirus Gc Glycoprotein to Generate a Broadly-Reactive Hantavirus-Specific Monoclonal Antibody
por: Zvirbliene, Aurelija, et al.
Publicado: (2014)

Updated Recommendations for Use of MenB-FHbp Serogroup B Meningococcal Vaccine — Advisory Committee on Immunization Practices, 2016
por: Patton, Monica E., et al.
Publicado: (2017)

Cost-effectiveness of alternative strategies for vaccination of adolescents against serogroup B IMD with the MenB-FHbp vaccine in Canada
por: Breton, Marie-Claude, et al.
Publicado: (2020)

Predicted strain coverage of a meningococcal multicomponent vaccine (4CMenB) in Portugal
por: Simões, Maria João, et al.
Publicado: (2017)

A Multi-Component Meningococcal Serogroup B Vaccine (4CMenB): The Clinical Development Program
por: O’Ryan, Miguel, et al.
Publicado: (2013)

Diversity of greek meningococcal serogroup B isolates and estimated coverage of the 4CMenB meningococcal vaccine
por: Tzanakaki, Georgina, et al.
Publicado: (2014)

OpcA and PorB are novel bactericidal antigens of the 4CMenB vaccine in mice and humans
por: Viviani, Viola, et al.
Publicado: (2023)

Generation of recombinant single-chain antibodies neutralizing the cytolytic activity of vaginolysin, the main virulence factor of Gardnerella vaginalis
por: Pleckaityte, Milda, et al.
Publicado: (2011)

Genomic Characterization of Invasive Meningococcal Serogroup B Isolates and Estimation of 4CMenB Vaccine Coverage in Finland
por: Bodini, Margherita, et al.
Publicado: (2020)

Safety and immunogenicity of co-administered meningococcal serogroup B (4CMenB) vaccine: A literature review
por: Abitbol, Véronique, et al.
Publicado: (2023)

Reconstitution of Cholesterol-Dependent Vaginolysin into Tethered Phospholipid Bilayers: Implications for Bioanalysis
por: Budvytyte, Rima, et al.
Publicado: (2013)

Progressive Decrease in the Potential Usefulness of Meningococcal Serogroup B Vaccine (4CMenB, Bexsero®) in Gipuzkoa, Northern Spain
por: Pérez-Trallero, Emilio, et al.
Publicado: (2014)

4CMenB Immunization Induces Serum Bactericidal Antibodies Against Non-Serogroup B Meningococcal Strains in Adolescents
por: Biolchi, Alessia, et al.
Publicado: (2020)

Cross-reactivity of 4CMenB vaccine-induced antibodies against meningococci belonging to non-B serogroups in Italy
por: Fazio, Cecilia, et al.
Publicado: (2021)

Sex, Age, and Race Effects on Immunogenicity of MenB-FHbp, A Bivalent Meningococcal B Vaccine: Pooled Evaluation of Clinical Trial Data
por: Beeslaar, Johannes, et al.
Publicado: (2020)

02. Beyond B Antigen Coverage: The Potential of the 4CMenB Vaccine for Cross-protection Against Pathogenic Neisseria Infections
por: Garcia, Yara Ruiz, et al.
Publicado: (2021)

Evaluation of strain coverage of the multicomponent meningococcal serogroup B vaccine (4CMenB) administered in infants according to different immunisation schedules
por: Biolchi, Alessia, et al.
Publicado: (2019)

Characterization of a Panel of Cross-Reactive Hantavirus Nucleocapsid Protein-Specific Monoclonal Antibodies
por: Avižinienė, Aliona, et al.
Publicado: (2023)

2722. Effects of Sex, Age, and Race on Immunogenicity of MenB-FHbp, a Bivalent Meningococcal B Vaccine: A Pooled Evaluation of Clinical Trial Data
por: Beeslaar, Johannes, et al.
Publicado: (2019)

Characterization of meningococcal carriage isolates from Greece by whole genome sequencing: Implications for 4CMenB vaccine implementation
por: Kesanopoulos, Konstantinos, et al.
Publicado: (2018)

Potential Coverage of the 4CMenB Vaccine against Invasive Serogroup B Neisseria meningitidis Isolated from 2009 to 2013 in the Republic of Ireland
por: Mulhall, Robert M., et al.
Publicado: (2018)

The serogroup B meningococcal outer membrane vesicle-based vaccine 4CMenB induces cross-species protection against Neisseria gonorrhoeae
por: Leduc, Isabelle, et al.
Publicado: (2020)

A re-assessment of 4CMenB vaccine effectiveness against serogroup B invasive meningococcal disease in England based on an incidence model
por: Argante, Lorenzo, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_uctmq8ja6hpi4o2mm09oe7c10u